201 related articles for article (PubMed ID: 2884807)
21. [Chronic treatment of schizophrenia with injectable bromperidol decanoate].
Suárez Richards M
Acta Psiquiatr Psicol Am Lat; 1985 Sep; 31(3):222-8. PubMed ID: 2870608
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].
Levi Minzi A; Laviani M
Minerva Psichiatr; 1992; 33(1):51-5. PubMed ID: 1406161
[TBL] [Abstract][Full Text] [Related]
23. Haloperidol decanoate: injection site reactions.
Maharaj K; Guttmacher LB; Moeller R
J Clin Psychiatry; 1995 Apr; 56(4):172-3. PubMed ID: 7713859
[No Abstract] [Full Text] [Related]
24. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
De Cuyper H; Bollen J; van Praag HM; Verstraeten D
Br J Psychiatry; 1986 May; 148():560-6. PubMed ID: 2877701
[TBL] [Abstract][Full Text] [Related]
25. Parenteral haloperidol in psychiatric emergencies. Double-blind comparison with chlorpromazine.
Gerstenzang ML; Krulisky TV
Dis Nerv Syst; 1977 Aug; 38(8):581-3. PubMed ID: 328243
[TBL] [Abstract][Full Text] [Related]
26. Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.
Adetunji B; Basil B; Mathews M; Williams A; Osinowo T
J Clin Psychiatry; 2006 Mar; 67(3):497; author reply 497-8. PubMed ID: 16649843
[No Abstract] [Full Text] [Related]
27. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
Morasiewicz J; Baranowski P; Borys J; Jańska-Skomorowska M; Kiejna A
Psychiatr Pol; 1995; 29(3):405-20. PubMed ID: 7652093
[TBL] [Abstract][Full Text] [Related]
28. A loading-dose strategy for converting from oral to depot haloperidol.
Ereshefsky L; Toney G; Saklad SR; Anderson C; Seidel D
Hosp Community Psychiatry; 1993 Dec; 44(12):1155-61. PubMed ID: 7907570
[TBL] [Abstract][Full Text] [Related]
29. Use of haloperidol decanoate in psychiatric diseases.
Zonda T; Kövári E
Ther Hung; 1992; 40(2):64-8. PubMed ID: 1361081
[TBL] [Abstract][Full Text] [Related]
30. Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length.
Brahm NC; Washington NB
J Pharm Pract; 2011 Dec; 24(6):561-3. PubMed ID: 22048930
[TBL] [Abstract][Full Text] [Related]
31. [Acute psychosis: in an emergency always still haloperidol?].
Möller HJ
Dtsch Med Wochenschr; 2008 Jan; 133(3):96. PubMed ID: 18186013
[No Abstract] [Full Text] [Related]
32. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
[TBL] [Abstract][Full Text] [Related]
33. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
Resnick M; Burton BT
J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
[TBL] [Abstract][Full Text] [Related]
34. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
Roncoroni D
Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
[TBL] [Abstract][Full Text] [Related]
35. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study.
Deberdt R; Elens P; Berghmans W; Heykants J; Woestenborghs R; Driesens F; Reyntjens A; van Wijngaarden I
Acta Psychiatr Scand; 1980 Oct; 62(4):356-63. PubMed ID: 7468294
[TBL] [Abstract][Full Text] [Related]
36. Haloperidol decanoate in children.
Alessi N; Alkhouri I; Fluent T; Quinlan P; Williams K
J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865-6. PubMed ID: 11501680
[No Abstract] [Full Text] [Related]
37. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
38. Haloperidol decanoate (Janssen) in the treatment of schizophrenia.
Zbytovský J
Cesk Psychiatr; 1993 Jan; 89(1):27-9. PubMed ID: 8099537
[TBL] [Abstract][Full Text] [Related]
39. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
40. Rapid tranquilization: the efficacy of oral concentrate.
Dubin WR; Waxman HM; Weiss KJ; Ramchandani D; Tavani-Petrone C
J Clin Psychiatry; 1985 Nov; 46(11):475-8. PubMed ID: 2865251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
